Early treatment correlates with better immune fitness, marked by higher CD4-positive naive T cells and a favorable tumor microenvironment. Cilta-cel therapy shows improved outcomes in earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback